Ceria nanoparticles prophylactic used for renal ischemia-reperfusion injury treatment by attenuating oxidative stress and inflammatory response
2022 · Biomaterials · 85 citations
https://doi.org/10.1016/j.biomaterials.2022.121686
Y
Yonghui Wu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
47
Papers
770
Citations
15
h-index
19
i10-index
Yonghui Wu is an academic researcher from Harbin Medical University. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Advanced Nanomaterials in Catalysis & MicroRNA in disease regulation. The author has an h-index of 15, co-authored 40 publications.
ORCID: 0000-0001-5021-9949Papers by this author
worksMetformin alleviates nickel-refining fumes-induced aerobic glycolysis via AMPK/GOLPH3 pathway in vitro and in vivo
2022 · Ecotoxicology and Environmental Safety · 10 citations
https://doi.org/10.1016/j.ecoenv.2022.113461
Carvacrol/cyclodextrin/ceria nanoparticle/hyaluronate hybrid microneedle for promoted diabetic wound healing through the modulation of microenvironment
2024 · International Journal of Biological Macromolecules · 7 citations
https://doi.org/10.1016/j.ijbiomac.2024.139126
Clinical implications of miR-195 in cancer: mechanisms, potential applications, and therapeutic strategies
2025 · Journal of Cancer Research and Clinical Oncology · 5 citations
https://doi.org/10.1007/s00432-025-06195-w
Radiomics analysis based on CT for predicting lymph node metastasis and prognosis in duodenal papillary carcinoma
2024 · Insights into Imaging · 3 citations
https://doi.org/10.1186/s13244-024-01732-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat